U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H12O3
Molecular Weight 228.2433
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXYBENZONE

SMILES

COC1=CC=C(C(=O)C2=CC=CC=C2)C(O)=C1

InChI

InChIKey=DXGLGDHPHMLXJC-UHFFFAOYSA-N
InChI=1S/C14H12O3/c1-17-11-7-8-12(13(15)9-11)14(16)10-5-3-2-4-6-10/h2-9,15H,1H3

HIDE SMILES / InChI
Oxybenzone is one of the more popular molecules used by chemists during the manufacturing of cosmetics and is included in sunscreen for UV protection. The chemical is often used to stabilize and strengthen the color and scent of skin care products, but its widest use is in the form of sun block. Unfortunately, the debate about the safety of oxybenzone is still ongoing. One of the biggest concerns in the medical community about the widespread use of the molecule comes from the fact that it’s easily absorbed into the body. This absorption raises concerns that oxybenzone may accumulate in the body, eventually leading to potentially toxic levels of the chemical, which can affect the endocrine system.

Originator

Sources: DD21053

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
SHADE UVAGUARD

Approved Use

To prevent sunburns.

Launch Date

1992
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
94.2 ng/mL
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
258.1 ng/mL
2 mg/cm² 4 times / day multiple, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: MULTIPLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
85.4 ng/mL
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
180.1 ng/mL
2 mg/cm² 4 times / day multiple, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: MULTIPLE
co-administered:
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1204 ng × h/mL
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3443.7 ng × h/mL
2 mg/cm² 4 times / day multiple, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: MULTIPLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1159.6 ng × h/mL
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2757.3 ng × h/mL
2 mg/cm² 4 times / day multiple, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: MULTIPLE
co-administered:
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
78.5 h
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
79.2 h
2 mg/cm² single, topical
dose: 2 mg/cm²
route of administration: Topical
experiment type: SINGLE
co-administered: AVOBENZONE
OXYBENZONE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
10 % single, topical
Accidental dose
Dose: 10 %
Route: topical
Route: single
Dose: 10 %
Sources:
unknown
Health Status: unknown
Sex: F
Food Status: UNKNOWN
Sources:
Other AEs: Eczema...
6 % 4 times / day multiple, topical
Recommended
Dose: 6 %, 4 times / day
Route: topical
Route: multiple
Dose: 6 %, 4 times / day
Sources:
unknown
Health Status: unknown
Sex: M+F
Food Status: UNKNOWN
Sources:
Other AEs: Rash...
Other AEs:
Rash (16.7%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Eczema
10 % single, topical
Accidental dose
Dose: 10 %
Route: topical
Route: single
Dose: 10 %
Sources:
unknown
Health Status: unknown
Sex: F
Food Status: UNKNOWN
Sources:
Rash 16.7%
6 % 4 times / day multiple, topical
Recommended
Dose: 6 %, 4 times / day
Route: topical
Route: multiple
Dose: 6 %, 4 times / day
Sources:
unknown
Health Status: unknown
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Quantification of organic eluates from polymerized resin-based dental restorative materials by use of GC/MS.
2007-05-01
Determination of UV filters and antimicrobial agents in environmental water samples.
2007-02
Expression of osteoblast marker genes in rat calvarial osteoblast-like cells, and effects of the endocrine disrupters diphenylolpropane, benzophenone-3, resveratrol and silymarin.
2006-12-15
Parabens as urinary biomarkers of exposure in humans.
2006-12
Endocrine disruptors and rat adrenocortical function: studies on freshly dispersed and cultured cells.
2006-12
A validated method for the determination of traces of UV filters in fish using LC-MS/MS.
2006-11
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Simultaneous determination of benzophenone-type UV filters in water and soil by gas chromatography-mass spectrometry.
2006-10-27
Sunscreen enhancement of UV-induced reactive oxygen species in the skin.
2006-10-15
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group.
2006-10
Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1alpha gene expression in primary culture of rat calvarial osteoblast-like cells.
2006-10
Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy.
2006-08-01
Causal agents of photoallergic contact dermatitis diagnosed in the national institute of dermatology of Colombia.
2006-08
Photoallergic contact cheilitis due to oxybenzone found in a lip cosmetic.
2006-07
Activity related to the carcinogenicity of plastic additives in the benzophenone group.
2006-06-01
Bioactive constituents from Chinese natural medicines. XVII. constituents with radical scavenging effect and new glucosyloxybenzyl 2-isobutylmalates from Gymnadenia conopsea.
2006-04
Estrogenic activities of chemicals related to food contact plastics and rubbers tested by the yeast two-hybrid assay.
2006-04
Comparison of in vitro and in vivo estrogenic activity of UV filters in fish.
2006-04
In vitro permeation of repellent DEET and sunscreen oxybenzone across three artificial membranes.
2006-03-09
Photocontact allergy to oxybenzone and contact allergy to lignocaine and prilocaine.
2006-03
Photoallergic contact dermatitis from ketoprofen in southern Sweden.
2006-03
Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation.
2006-02
Evaluation of the photostability of different UV filter combinations in a sunscreen.
2006-01-13
Influence of complexation with cyclodextrins on photo-induced free radical production by the common sunscreen agents octyl-dimethylaminobenzoate and octyl-methoxycinnamate.
2006-01
In vivo bioassay-guided fractionation of marine sediment extracts from the Southern California Bight, USA, for estrogenic activity.
2005-11
Separation via flotation, spectrophotometric speciation, and determination of vanadium(IV) in wastes of power stations.
2005-11
Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells.
2005-10-15
Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry.
2005-10
Photoallergic and allergic reaction to 2-hydroxy-4-methoxybenzophenone (sunscreen) and allergy to cetyl alcohol in cosmetic cream.
2005-09
Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells.
2005-09
Fading of artificial hair color and its prevention by photofilters.
2005-08-09
Simultaneous analysis of insect repellent DEET, sunscreen oxybenzone and five relevant metabolites by reversed-phase HPLC with UV detection: application to an in vivo study in a piglet model.
2005-08-05
[Estrogenic activity of ultraviolet absorbers and the related compounds].
2005-08
Assay of common sunscreen agents in suncare products by high-performance liquid chromatography on a cyanopropyl-bonded silica column.
2005-06-15
The effect of packaging materials on the stability of sunscreen emulsions.
2005-06-13
In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations.
2005-06
Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks.
2005-02-27
Occurrence of some organic UV filters in wastewater, in surface waters, and in fish from Swiss Lakes.
2005-02-15
Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays.
2005-02
Sunscreens - which and what for?
2004-12-13
Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats.
2004-12-01
Unexpected photolysis of the sunscreen octinoxate in the presence of the sunscreen avobenzone.
2004-11-25
Sunscreen penetration of human skin and related keratinocyte toxicity after topical application.
2004-09-28
Recrystallization in different sunscreen formulations after cutaneous application.
2004-07
Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans.
2004-07
[First derivative spetrophotometric direct determination of 2-hydroxy-4-methoxybenzo phenone in polyester resin by computer assistant].
2004-06
In-vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone.
2004-05
Occurrence of UV filter compounds from sunscreens in surface waters: regional mass balance in two Swiss lakes.
2004-05
Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers.
2004-04-25
Contact and photocontact allergy to ketoprofen. The Belgian experience.
2004-04
Patents

Sample Use Guides

Apply evenly and liberally to all exposed areas of the skin 30 minutes before any sun exposure.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
BENZOPHENONE-3
INCI   VANDF  
INCI  
Preferred Name English
OXYBENZONE
HSDB   INN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
ONGROSTAB HMB
Common Name English
SHADE UVAGUARD COMPONENT OXYBENZONE
Common Name English
OXYBENZONE [USP-RS]
Common Name English
oxybenzone [INN]
Common Name English
ADVASTAB 45
Common Name English
VIOSORB 110
Common Name English
Oxybenzone [WHO-DD]
Common Name English
BENZOPHENONE-3 [VANDF]
Common Name English
OXYBENZONE [MART.]
Common Name English
OXYBENZONE [MI]
Common Name English
OXYBENZONE [USP MONOGRAPH]
Common Name English
OXYBENZONE [HSDB]
Common Name English
NSC-7778
Code English
OXYBENZONE [ORANGE BOOK]
Common Name English
UVINUL 40
Brand Name English
OXYBENZONE [USAN]
Common Name English
2-Hydroxy-4-methoxybenzophenone
Systematic Name English
TINOSORB B 3
Common Name English
OXYBENZONE [VANDF]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 352.10
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
EPA PESTICIDE CODE 691
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
CFR 21 CFR 352.20
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
FDA ORPHAN DRUG 142401
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
NCI_THESAURUS C851
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
Code System Code Type Description
WIKIPEDIA
OXYBENZONE
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
RXCUI
32673
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY RxNorm
ChEMBL
CHEMBL1625
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
INN
2096
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
DRUG CENTRAL
3412
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
SMS_ID
100000083280
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
CAS
131-57-7
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID3022405
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
NSC
7778
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
EVMPD
SUB09556MIG
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
DRUG BANK
DB01428
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
RS_ITEM_NUM
1485001
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
NCI_THESAURUS
C47646
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
CHEBI
34283
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
HSDB
4503
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
PUBCHEM
4632
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-031-5
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
FDA UNII
95OOS7VE0Y
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
DAILYMED
95OOS7VE0Y
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
MESH
C005290
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY
MERCK INDEX
m8323
Created by admin on Mon Mar 31 17:52:17 GMT 2025 , Edited by admin on Mon Mar 31 17:52:17 GMT 2025
PRIMARY Merck Index